Tianshui Zhongxing Bio-Technology adjusts investment, guarantees, and manages wealth
Tianshui Zhongxing Bio-Technology has updated its RMB 700 million investment in the food and medicinal fungi industrial park project in Jintang County through a supplementary agreement. The first phase's leased area has been reduced from 159,100 square meters to 132,000 square meters, with the annual rent decreasing from RMB 14.85 million to approximately RMB 12.30 million. The second phase's land acquisition increased to 100 mu, while the total investment remains unchanged. This adjustment was made due to the lessor's inability to deliver some factory buildings on schedule.
Additionally, the company has provided guarantees for its wholly-owned subsidiaries and wholly-owned sub-subsidiaries for 2025. This includes a maximum guarantee of RMB 30 million for Jiangsu Zhongyou Xinghe Edible Fungi Technology Co., Ltd., and RMB 20 million each for Anyang Zhongxing Bio-Technology Co., Ltd., Xinxiang Xinghe Bio-Technology Co., Ltd., and Shandong Zhongxing Bio-Technology Co., Ltd. These guarantees, totaling RMB 112,912,550, account for 34.04% of the company's net assets as of December 31, 2024.
The company also reported on its wealth management activities, redeeming several products totaling RMB 270 million and subscribing to new products, including Pacific Securities Jinyuanbao No. 8 Collective Asset Management Plan (RMB 30 million), Hualong Securities Youying Exclusive No. 2 Single Asset Management Plan (RMB 30 million), China Post Securities Hongyu No. 1 Collective Asset Management Plan (RMB 50 million), and Caida Zunxiang No. 11 Collective Asset Management Plan (RMB 10 million). As of the announcement date, the company held RMB 370 million in wealth management products.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Tianshui Zhongxing Bio-Technology publishes news
Free account required • Unsubscribe anytime